Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New location listings were added across multiple countries and regions, and several existing locations were removed. A revision tag Revision: v3.3.3 is shown.
    Difference
    2%
    Check dated 2025-12-23T08:19:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Publications section updated to note that items are automatically filled from PubMed, and the revision tag updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T18:52:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The funding/update notice about potential data delays and NIH operations status has been removed from the page.
    Difference
    0.2%
    Check dated 2025-11-17T18:02:17.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added the RUXCOVID Lancet Rheumatol 2022 publication citation with full author list and DOI. Removed the Lancet Rheumatol 2024 erratum notice.
    Difference
    0.3%
    Check dated 2025-11-03T12:42:27.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Updated citation (with erratum) and operating status notice added; older citation and earlier revision removed. The page now references the corrected citation version (v3.2.0) and includes current government operating status information.
    Difference
    3%
    Check dated 2025-10-05T17:28:09.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added revision v3.1.0; removed several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while updating version from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T10:15:14.000Z thumbnail image

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.